Ultragenyx Pharmaceutical Inc. is an American biopharmaceutical company involved in the research and development of novel products for treatment of rare and ultra-rare genetic diseases for which there are typically no approved treatments and high unmet medical need. Wikipedia
RARE (NasdaqGS) $43.89 -1.38 (-3.05%)
Wed, Jul 17, 2024, 4:00PM EDT